Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Molecular Templates (MTEM)
:MTEM
Holding MTEM?
Track your performance easily
MTEM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.00 - $4.12
Previous CloseN/A
Volume37.83K
Average Volume (3M)9.78M
Market Cap
$13.17K
Enterprise ValueN/A
Total Cash (Recent Filing)$23.55M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.70
Shares Outstanding6,583,880
10 Day Avg. Volume224,204
30 Day Avg. Volume9,779,804
Standard Deviation0.24
R-Squared0.08
Alpha-0.10
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Molecular Templates News
PremiumCompany Announcements
Molecular Templates Announces Leadership Changes and Operational Wind Down
PremiumCompany Announcements
Molecular Templates Announces Key Leadership Transition
MTEM FAQ
What was Molecular Templates’s price range in the past 12 months?
Molecular Templates lowest stock price was $0.00 and its highest was $4.12 in the past 12 months.
What is Molecular Templates’s market cap?
Molecular Templates’s market cap is $13.17K.
When is Molecular Templates’s upcoming earnings report date?
Molecular Templates’s upcoming earnings report date is Mar 27, 2025 which is in 68 days.
How were Molecular Templates’s earnings last quarter?
Currently, no data Available
Is Molecular Templates overvalued?
According to Wall Street analysts Molecular Templates’s price is currently Overvalued.
Does Molecular Templates pay dividends?
Molecular Templates does not currently pay dividends.
What is Molecular Templates’s EPS estimate?
Molecular Templates’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Molecular Templates have?
Molecular Templates has 6,583,880 shares outstanding.
What happened to Molecular Templates’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Molecular Templates?
Currently, no hedge funds are holding shares in MTEM
---
Company Description
Molecular Templates
Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded on October 17, 2001 and is headquartered in Austin, TX.
---
Technical Analysis
Adaptimmune Therapeutics
―
Corvus Pharmaceuticals
―
Cellectar Biosciences
―
Gritstone bio
―
---